In this regard, it is assumed that Nor1 upregulates the expression of hypertrophy markers and additionally promotes PARP-1 activation, resulting in functional impairment and progression of cardiac hypertrophy and heart failure [9]. Here, PARP1 is linked to cardiac hypertrophy.